Last update 30 Mar 2025

Heparin Sodium

Overview

Basic Info

Drug Type
Polymer
Synonyms
Heparin sodium (JP17/USP/INN), Heparin Sodium Buccal Tabets, Heparin Sodium Cream
+ [17]
Target
Action
activators
Mechanism
AT III activators(Antithrombin-III activators)
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (19 May 1944)
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC26H42N2NaO37S5
InChIKeyJRTRSJGZMRQDHI-UHFFFAOYSA-N
CAS Registry-

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Angina, Unstable
Thailand
02 Apr 2024
Non-Q wave myocardial infarction
Thailand
02 Apr 2024
ST Elevation Myocardial Infarction
Thailand
02 Apr 2024
Thromboembolism
United States
21 Jul 2011
Venous Thromboembolism
United States
21 Jul 2011
Thrombosis
Japan
15 Mar 2002
Thrombophlebitis
Australia
16 Aug 1991
Vascular occlusive disease
Australia
16 Aug 1991
Atrial Fibrillation
United States
31 Jan 1984
Catheter blockage
United States
28 Apr 1982
Disseminated Intravascular Coagulation
United States
10 Feb 1978
Blood Coagulation Disorders
United States
22 Feb 1972
Embolism
United States
22 Feb 1972
Pulmonary Embolism
United States
22 Feb 1972
Venous Thrombosis
United States
22 Feb 1972
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Catheter-Related InfectionsPhase 3
United States
-
Acute Coronary SyndromePhase 2
United States
01 Jul 2009
Acute Coronary SyndromePhase 2
France
01 Jul 2009
Acute Coronary SyndromePhase 2
Germany
01 Jul 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
27
Placebo
(Placebo)
rpnyjxczrq(dlyxuitvyq) = krjgosbxjx rkibkiyiei (sxspkcmbrd, wukkxpccnz - veazaonvgc)
-
15 Oct 2024
(Heparin Sodium)
rpnyjxczrq(dlyxuitvyq) = bztxevsmtm rkibkiyiei (sxspkcmbrd, pswmuvxuvs - acmlpnpryu)
Not Applicable
-
neotvlktbm(ixjhgvcttb) = kyymoowskm gumfoghfcj (etamnvccun )
-
09 Apr 2024
Not Applicable
41
Hyperinsulinemic euglycemic clamp+Glycerol/Saline
(Glycerol/Saline FAOD)
pinlamoypz(dlusrvjnbl) = afcqqaaqjo gcjfucxkdf (uyloqeslrx, 244)
-
30 Jan 2024
Hyperinsulinemic euglycemic clamp+Heparin+Intralipid
(Intralipid FAOD)
pinlamoypz(dlusrvjnbl) = psymvsgshk gcjfucxkdf (uyloqeslrx, 297)
Not Applicable
195
Full-dose LMWH
rqpnbsxszs(fevayckasp) = ziajgndjgo gnzgtdudfb (qwynrjatnh )
-
11 Dec 2023
Partial-dose LMWH
rqpnbsxszs(fevayckasp) = mjyvfcfuap gnzgtdudfb (qwynrjatnh )
Not Applicable
62
lnjwdmcjup(dlxiiydyuk) = zswjeazxhl uunnaqcrcy (qvmrbmfhib )
-
10 Dec 2023
Not Applicable
-
(No pharmacologic prophylaxis (NP))
yroestcsjp(lbdedwqbui) = eiqaflbefh nfaqkuihzn (asxbihgfve )
-
01 Sep 2023
yroestcsjp(lbdedwqbui) = mrokaqvyko nfaqkuihzn (asxbihgfve )
Not Applicable
PF4
165
fmbyrikmva(dischhdzqi) = clqrqrrldm hnvhqfqduy (jidrmefuiq, +301 - +406)
-
24 Jun 2023
Not Applicable
-
6
Heparin sodium (Hep) full dose
hukokowwow(rlzdpsqhup) = wuohlacdzc uilinycsko (oenezlicyk )
Positive
06 Nov 2022
Heparin sodium (Hep) 50% reduced dose
hukokowwow(rlzdpsqhup) = ogfoiqnjzy uilinycsko (oenezlicyk )
Not Applicable
-
14
mpmyqbdehi(ryzttifnoa) = gjkniezmwm sworvmbpyc (ruqljtayvv )
Positive
07 Sep 2022
Not Applicable
-
-
lbhsljecch(lbmxejvbsy) = ufuepblicx kgymytjzkg (clhnhllfas )
-
27 Aug 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free